China Healthcare Industry China Healthcare Consulting Presentation Outline Market Background...

17
China Healthcare Consulting China Healthcare Industry Presentation Outline Market Background Regulatory Environment Industry Issues Intellectual Property Rights Growth Sectors Conclusions

Transcript of China Healthcare Industry China Healthcare Consulting Presentation Outline Market Background...

China Healthcare Consulting

China Healthcare Industry

Presentation OutlineMarket BackgroundRegulatory EnvironmentIndustry IssuesIntellectual Property RightsGrowth SectorsConclusions

China Healthcare Consulting

China Healthcare Industry

NOTICE from CHCCOnly Selected Slides are Shown on our website

Detailed Slides and Presentation can be available upon request

China Healthcare Consulting

China Healthcare Industry

China- the fastest growing market in the world

China GDP and Growth Rate

0

2000

4000

6000

8000

10000

12000

Year

1987

1989

1991

1993

1995

1997

1999

Bil

lio

n Y

uan

0%

5%

10%

15%

20%

25%

30%

35%

40%

GDP

GDPGrowthrate

China Healthcare Consulting

China Healthcare Industry

China- Import vs Export

China Export, Import, Ex Rate, Balance

-50.0

0.0

50.0

100.0

150.0

200.0

250.0

300.0

Year

1985

1986

1987

1988

1989

1990

1991

1992

1993

1994

1995

1996

1997

1998

1999

2000

$Bil

liio

n

0

100

200

300

400

500

600

700

800

900

1000

100

Yu

an v

s $

Exports

Imports

Balance

Ex. Rate

China Healthcare Consulting

China Healthcare Industry

Strong Hard Currency Reserve

China US$ Reserve

0

50

100

150

200

Year

$B

illio

n

China Healthcare Consulting

China Healthcare Industry

Increasing U.S. Direct Investment into China

0

10

20

30

40

50

Year

$Bill

ion

China Healthcare Consulting

China Healthcare Industry

China Pharmaceutical Industry Output & Growth Rate ---A Large and Growing Market

China Pharmceutical Industry Output & Growth Rate

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

19911992199319941995199619971998199920002001

Year

0

50

100

150

200

250

300

Bil

lio

n Y

ua

n

GrowthRate

IndustryOutput

China Healthcare Consulting

China Healthcare Industry

China Pharmaceutical Commercial Sales & Growth Rate (Billion Yuan)

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001Year

0

20

40

60

80

100

120

140

GrowthRate

CommercialSales

China Healthcare Consulting

China Healthcare Industry

Rank of Drug sales in 14 major area 2001 China

2001 2000 Company1 1 Shanghai Roche

2 3 Shanghai BMS

3 2 Dalian Pfizer

4 7 Merck Sharp & Dohme

5 6 Glaxo

6 8 Beijing Double-Crane pharm.

7 10 Sino-Swed Pharm Corp

8 4 North China Group

9 5 Sandoz

10 12 Harbin Pharm. Group

11 16 Novartis

12 9 J&J

13 11 Astra-Zeneca

14 17 Bayer

15 34 Shandon Lu Nan Pharm.

China Healthcare Consulting

China Healthcare Industry

Problems in Healthcare System Lack of Stable Budget ResourcesGreat Variability in Ability to Pay by EmployersCasual Attitudes toward Medical ExpenditureIncompatible with New Ownership StructureDeferred Payment Causes Resentment and Social Problems

China Healthcare Consulting

China Healthcare Industry

SDAMerger of 3 Former Governmental DepartmentsCompositionDepartment of Drug Registration

• Synthetic, Biological and TCM Divisions

Department of Medical Devices• Standards, Product Registration and

Supervision DivisionsDepartment of Safety SupervisionDepartment of Market Compliance

China Healthcare Consulting

China Healthcare Industry

IPR Counterfeiting of TrademarksLax Enforcement of Law and Protection of Local IndustryWTO Accession Exempts China From Giving Immediate Patent ProtectionAdministrative Protection (AP) is Rumoured to be Phased Out in Favour of 20-Year PatentPre-AP Local Generics Considered LegalRequirement of Large Generic Prints on Labels

China Healthcare Consulting

China Healthcare Industry

WTO Challenges (1)

Regulatory EnvironmentMore in Line With International

StandardsMore Transparent Administration ICH Guideline Increasingly More

RelevantAdministrative Barriers to Offset WTO

Requirements

China Healthcare Consulting

China Healthcare Industry

Biological ProductsTypes Biochemical, Biological and Genetically

Engineered Products

Science and Technology DrivenAverage Growth Rate 12.5% Worldwide Compared with 8% for PharmaceuticalsUS$ 20 Billion in 2000 with 100+ Products

China Healthcare Consulting

China Healthcare Industry

OTC Market in China

• 700 OTC, 70 % will be registered as OTC• Urbanization. Large migration from rural• Sales by chain pharmacies in coastal cities increased by 45% in

2001. • Foreign companies allowed to run OTC distribution

China Healthcare Consulting

China Healthcare Industry

TCM: Traditional Chinese Medicine

TCM Source Materials Number Over 12,000TCM Industry Produces 5,000+ TCM Preparations in Large-Scale ProductionTCM Sector Outperforms Average Medical Industry’s Performance IndicatorsRide on the Back of Strong Worldwide Demand for Natural Medicines

China Healthcare Consulting

China Healthcare Industry

MORE

Chinese Hospitals

China’s healthcare system